Clinical trial
Feasibility Study for Investigating the Effect of Caffeine Consumption on Protein Biomarkers Related to Cardiovascular Disease
NCT06359197 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study for Investigating the Effect of Caffeine Consumption on Protein Biomarkers Related to Cardiovascular Disease
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- April 8, 2024
- Completion date
- June 1, 2025
- Enrollment
- 36 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
healthy